CA Patent

CA2180206A1 — Freeze-dried preparation for pharmaceutical use

Assigned to Takeda Pharmaceutical Co Ltd · Expires 1996-12-31 · 29y expired

What this patent protects

A freeze-dried preparation comprising a bioactive substance having an optionally substituted amidino group and a disaccharide which stabilizes the bioactive substance; and a process for making the preparation are descrribed.

USPTO Abstract

A freeze-dried preparation comprising a bioactive substance having an optionally substituted amidino group and a disaccharide which stabilizes the bioactive substance; and a process for making the preparation are descrribed.

Drugs covered by this patent

dalbavancin-hydrochloride (DALBAVANCIN HYDROCHLORIDE)

Patent Metadata

Patent number: CA2180206A1
Jurisdiction: CA
Classification: —
Expires: 1996-12-31
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.